DE69529845T2 - Wärmebehandlung von blutplasmaproteinen - Google Patents

Wärmebehandlung von blutplasmaproteinen

Info

Publication number
DE69529845T2
DE69529845T2 DE69529845T DE69529845T DE69529845T2 DE 69529845 T2 DE69529845 T2 DE 69529845T2 DE 69529845 T DE69529845 T DE 69529845T DE 69529845 T DE69529845 T DE 69529845T DE 69529845 T2 DE69529845 T2 DE 69529845T2
Authority
DE
Germany
Prior art keywords
pct
heat treatment
sec
less
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69529845T
Other languages
English (en)
Other versions
DE69529845D1 (de
Inventor
Vance Mcintosh
Charles Hardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Common Services Agency
Original Assignee
Common Services Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Common Services Agency filed Critical Common Services Agency
Application granted granted Critical
Publication of DE69529845D1 publication Critical patent/DE69529845D1/de
Publication of DE69529845T2 publication Critical patent/DE69529845T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DE69529845T 1994-12-08 1995-12-08 Wärmebehandlung von blutplasmaproteinen Expired - Lifetime DE69529845T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424732.7A GB9424732D0 (en) 1994-12-08 1994-12-08 Heat treated blood plasma proteins
PCT/GB1995/002902 WO1996017631A1 (en) 1994-12-08 1995-12-08 Heat treated blood plasma proteins

Publications (2)

Publication Number Publication Date
DE69529845D1 DE69529845D1 (de) 2003-04-10
DE69529845T2 true DE69529845T2 (de) 2003-12-11

Family

ID=10765577

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529845T Expired - Lifetime DE69529845T2 (de) 1994-12-08 1995-12-08 Wärmebehandlung von blutplasmaproteinen

Country Status (10)

Country Link
US (1) US5831027A (de)
EP (1) EP0804254B1 (de)
JP (2) JP4181214B2 (de)
AT (1) ATE233576T1 (de)
CA (1) CA2206670C (de)
DE (1) DE69529845T2 (de)
DK (1) DK0804254T3 (de)
ES (1) ES2193206T3 (de)
GB (1) GB9424732D0 (de)
WO (1) WO1996017631A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
CA2308462C (en) 1997-11-17 2009-02-24 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
JP2001270900A (ja) * 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd フィブリノゲンのウイルス不活化法
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894830B1 (fr) * 2005-12-19 2008-04-04 Lab Francais Du Fractionnement Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
US9110008B2 (en) * 2010-07-26 2015-08-18 Los Gatos Research Method for isotopic analysis of water in bodily fluids
US20140287044A1 (en) * 2011-03-04 2014-09-25 Rare Antibody Antigen Supply, Inc. Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
EP3694322A1 (de) 2017-10-09 2020-08-19 Terumo BCT Biotechnologies, LLC Lyophilisierungsbehälter und verfahren zu seiner verwendung
US11754478B2 (en) 2018-08-16 2023-09-12 Abb Schweiz Ag Rapid equilibrator for water isotope analysis
EP3938742A1 (de) 2019-03-14 2022-01-19 Terumo BCT Biotechnologies, LLC Mehrteiliger lyophilisierungsbehälter und verwendungsverfahren

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
WO1984003628A1 (en) * 1983-05-09 1984-09-27 Nordisk Insulinlab A concentrate of the antihemophilic factor viii and a process for producing it
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
DE3577801D1 (de) * 1985-08-05 1990-06-28 Immuno Ag Verfahren zur herstellung von praeparationen auf basis von blutgerinnungsfaktoren.
CA1293941C (en) * 1985-11-08 1992-01-07 Maria Erlinda Co-Sarno Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
WO1988008710A1 (en) * 1987-05-15 1988-11-17 Rubinstein Alan I Sequential improved method for treatment of human blood-clotting factor products
US5099002A (en) * 1987-05-15 1992-03-24 University Of Southern California Sequential improved method for treatment of human blood-clotting factor products
DK708488D0 (da) * 1988-12-20 1988-12-20 Nordisk Gentofte Faktor i praeparat
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
AT402788B (de) * 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation

Also Published As

Publication number Publication date
WO1996017631A1 (en) 1996-06-13
CA2206670C (en) 2008-02-19
CA2206670A1 (en) 1996-06-13
AU4183296A (en) 1996-06-26
EP0804254A1 (de) 1997-11-05
GB9424732D0 (en) 1995-02-08
ES2193206T3 (es) 2003-11-01
DK0804254T3 (da) 2003-06-30
JP4181214B2 (ja) 2008-11-12
US5831027A (en) 1998-11-03
JPH10510257A (ja) 1998-10-06
EP0804254B1 (de) 2003-03-05
JP2008044963A (ja) 2008-02-28
AU692018B2 (en) 1998-05-28
DE69529845D1 (de) 2003-04-10
ATE233576T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
CA1199275A (en) Method of achieving hemostasis
EP0159311B1 (de) Verfahren zur Inaktivierung von vermehrungsfähigen filtrierbaren Krankheitserregern in Blutprodukten
CA2113660C (en) Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out
DE3400413C2 (de)
US5151499A (en) Production method for protein-containing composition
ATE233576T1 (de) Wärmebehandlung von blutplasmaproteinen
US5639730A (en) Method of producing a virus-safe biological preparation
CA2128795C (en) A virus-safe blood coagulation factor xiii preparation
EP0457370B1 (de) Verfahren zur Pasteurisierung des Gewebeproteins PP4
JPH02114A (ja) トロンビン凝固性蛋白質の濃縮物、その製造方法及びその治療的用途
CA1297011C (en) Method of producing a factor viii (ahf) containing fraction
NO138145B (no) Fremgangsmaate for fremstilling av et enzympreparat
DE2734427C3 (de) Verfahren zur Gewinnung von thrombinartigen Enzymen aus Schlangengiften
AU658238B2 (en) A process for the production of a virus-free concentrate of thrombin
US3227626A (en) Plasminogen heat sterilization
JPH06505494A (ja) Ｉｘ因子の調製
US4177262A (en) Plasminogen compositions containing preactivated plasminogens with or without native plasminogens, process for making same, pharmaceutical compositions and control of blood clots
KR960004021B1 (ko) 항혈액 응고제 및 그의 제조방법
US4386161A (en) Process for the preparation of incoagulable blood by means of proteolytic enzymes and protein concentrate prepared therefrom
IE70455B1 (en) Pasteurized glue for joining human or animal tissues
EP0401232B1 (de) Verfahren zur pasteurisierung von wässrigen lösungen von faktor viii
FI96918C (fi) Koostumus veriplasman stabiloimiseksi pastöroinnin aikana
Banerjee et al. Isolation and purification of a coagulant from snake venom of the species Bothrops jararaca and the study of its properties
EP0841954B1 (de) Verfahren zur herstellung eines virussicheren, therapeutischen, biologischen präparates
DE19623293C2 (de) Nicht-immunogene Faktor VIII-enthaltende Zusammensetzung und ein Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition